APTV vs ZYME · P/E 41, rev $19.71B vs rev $76.3M
Aptiv PLC (APTV) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the APTV and ZYME stock pages for the full models.
Not investment advice.